Uncategorized


Short Sleep Duration Linked to Multimorbidity

A prospective UK cohort study suggested that short sleep duration was associated with the onset of chronic disease and multimorbidity. The study included 7,864 (32.5% women) participants free of multimorbidity. Self-reported sleep duration was measured 6 times between 1985 and 2016. Incidence of multimorbidity was defined as having 2 or […]


Comparative Effectiveness of Common Glucose-Lowering Medications Used with Metformin

A US multicenter, parallel-group, comparative-effectiveness clinical trial showed that when added to metformin, insulin glargine and glucagon-like peptide-1 receptor agonist liraglutide were significantly, albeit modestly, more effective in achieving and maintaining target glycated hemoglobin levels than sulfonylurea glimepiride or dipeptidyl peptidase 4 inhibitor sitagliptin in patients with type 2 diabetes […]


Artificial Sweeteners Linked to CVD Risk

A French population based prospective cohort study suggests a potential direct association between higher artificial sweetener consumption (especially aspartame, acesulfame potassium, and sucralose) and increased cardiovascular disease (CVD) risk. The study included 103 388 participants of the web-based cohort (mean age 42.2 years, 79.8% female, 904 206 person years) from 2009 to […]


Most Muscle Symptoms with Statin Therapy Were Not Due to Statins

An individual participant data meta-analysis concluded that most (>90%) of all reports of muscle symptoms with statin therapy were not due to the statin, although statins did cause a small proportional increase in reports of muscle pain, largely during the first year of treatment. The analysis included 19 double-blind trials […]


Statins but Not PCSK9 Inhibition Linked to Adverse Neurocognitive Effects

A drug-target Mendelian randomization (MR) analysis indicated adverse neurocognitive effects related to statins but not proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition. Data were from a combined sample of ∼740,000 participants in predominantly European ancestry-based genome-wide association cohort studies. There was a neutral cognitive profile related to genetic PCSK9 inhibition, […]


Early Time-Restricted Eating Effective for Weight Loss

A US randomized clinical trial suggested that early time-restricted eating (eTRE) was more effective for weight loss than eating over a window of 12 or more hours. A total of 90 obese participants (mean body mass index, 39.6; age, 43 years; 80% female) received weight-loss treatment (energy restriction [ER] of […]


Comparative Effects of Sleeping Pills

A systematic review and network meta-analysis provided the most comprehensive data synthesis on pharmacological treatments for adults with insomnia. The study included 170 trials (36 interventions and 47 950 participants) in the systematic review and 154 double-blind, randomized controlled trials (30 interventions and 44 089 participants) for the network meta-analysis. Benzodiazepines, doxylamine, […]


Achieving T2D Treatment Goals May Extend Life Expectancy

A US decision analytical model suggested that achieving recommended goals of glycated hemoglobin (HbA1c), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and body mass index (BMI) may extend the life expectancy (LE) of people with type 2 diabetes (T2D). The model was calibrated to a nationally representative sample of […]


Healthy Lifestyle Linked to Longer Life without Dementia

A US prospective cohort study showed that a healthy lifestyle was associated with a longer life expectancy, and a larger proportion of their remaining years without Alzheimer’s dementia (AD). The study included 2449 participants aged 65 years and older (mean 76 years, 63% women, African American>50%) from 1993 to 2009, […]


Treatment for Mild Chronic Hypertension during Pregnancy Beneficial

A US open-label, multicenter, randomized trial concluded that in pregnant women with mild chronic high blood pressure (BP), a strategy of targeting BP<140/90 mm Hg was associated with better pregnancy outcomes than a strategy of reserving treatment only for severe high BP, with no increase in the risk of small-for-gestational-age […]